Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 245Lymphoid 240Myeloid 65Sarcoma 39Breast 38Plasma cell 29Classical hematology 26CNS 19Dermatologic 16Genitourinary 15Head & Neck 9Gynecologic 4Tumor-Agnostic 3Thoracic 3Other neoplasm 3Other solid neoplasm 2Other 2Gastrointestinal 1

Conditions

Mesothelioma, Malignant 2Solitary Fibrous Tumor, Pleural 1Mesothelioma 1

Interventions

Cisplatin 81Gemcitabine 58Carboplatin 57Irinotecan 56Paclitaxel 53Pemetrexed 47Docetaxel 39Nivolumab 33Fluorouracil 30Bevacizumab 27pembrolizumab 25Cyclophosphamide 24Capecitabine 24Oxaliplatin 22Leucovorin 21Topotecan 19durvalumab 17Erlotinib Hydrochloride 17Sorafenib 16Everolimus 16Etoposide 16Bortezomib 16Ipilimumab 15Injections 15atezolizumab 14Sunitinib 14Filgrastim 14Early Intervention, Educational 14alvocidib 13Sirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Methotrexate × Other solid neoplasm × Clear all
NCT02611037 2025-12-18

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
34 enrolled 12 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00354393 2025-07-15

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

The Cleveland Clinic

Phase 2 Completed
9 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡